Home › Funds › BIOS Capital Management, LP › CGTX

BIOS Capital Management, LP position in CGTX

COGNITION THERAPEUTICS INC · Health Care

BIOS Capital Management, LP reported holding 6,000,000 shares of CGTX (COGNITION THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$5.76B, representing 16.86% of its reported portfolio and ranking #3 among its reported holdings. BIOS Capital Management, LP has disclosed CGTX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)6.00M sh
Reported value held$5.76B
Portfolio Weight16.86%
First reportedQ4 2024
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How BIOS Capital Management, LP's CGTX position evolved

BIOS Capital Management, LP first disclosed a stake in CGTX in Q4 2024 at 6,000,000 shares (US$4.2M). The position peaked in Q3 2026 at 6,000,000 shares, worth US$5.76B. Across 8 filings, BIOS Capital Management, LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 6,000,000 shares valued at US$5.76B.

Quarter by quarter

QuarterSharesValueChange
Q4 2024 6.00M $4.21M New
Q1 2025 6.00M $2.52M Hold
Q2 2025 6.00M $1.86M Hold
Q3 2025 6.00M $8.10M Hold
Q4 2025 6.00M $8.10M Hold
Q1 2026 6.00M $4.56M Hold
Q2 2026 6.00M $6.90M Hold
Q3 2026 6.00M $5.76B Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CGTX and 13F data

CGTX (COGNITION THERAPEUTICS INC) is a Health Care company. 32 other funds we track also report a position in CGTX — the largest reported positions include Chescapmanager LLC (US$957K), Dauntless Investment Group, LLC (US$427K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CGTX

All CGTX fund holders →

FAQ

How long has BIOS Capital Management, LP held CGTX?

BIOS Capital Management, LP has disclosed CGTX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is BIOS Capital Management, LP's current position in CGTX?

As of Q3 2026, BIOS Capital Management, LP holds 6.00M shares of CGTX (COGNITION THERAPEUTICS INC), valued at $5.76B, representing 16.86% of its reported portfolio and ranking #3.

Has BIOS Capital Management, LP been buying or selling CGTX?

In the latest 13F filing (Q3 2026), BIOS Capital Management, LP held unchanged its position in CGTX. The position peaked in Q3 2026 at 6.00M shares.

Which other funds hold CGTX?

Other major institutional holders of CGTX include Chescapmanager LLC, Dauntless Investment Group, LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.